Several aspects of the role and mechanism of YTHDF1, YTHDF2, YTHDC1, and IGF2BPs in RCC have been explained in the previous sections (Ying et al., 2021; Shen et al., 2022a; Xu et al., 2022a; Shen et al., 2022b; Chen et al., 2022; Liu et al., 2022c; Liu et al., 2022d; Zhang et al., 2022). Here, YTHDC1 is linked to renal cell adenocarcinoma.